Drug intelligence / Profile preview

solidaginis herba extract

Development stage
Unknown
Administration
Oral, Topical
01

Overview

**Solidaginis herba extract** is a herbal preparation derived from the dried, flowering aerial parts of plants of the genus Solidago, commonly *Solidago virgaurea* (European goldenrod) or *Solidago canadensis* (Canadian goldenrod)[1][3][5]. This extract contains a rich array of bioactive constituents including **flavonoids** (e.g., quercetin, kaempferol, rutin), **phenolic acids** (e.g., caffeic, chlorogenic, gallic, ferulic, vanillic), **triterpene saponins** (oleanane-type), and essential oils (e.g., germacrene D, limonene, bornyl acetate)[1][3]. It is traditionally and empirically used as a **diuretic**, for **urinary tract irrigation** (especially in cases of inflammation and renal gravel), and as an **adjuvant in the treatment of bacterial infections of the urinary tract**[3][8]. Experimental and clinical evidence shows **anti-inflammatory**, **antioxidant**, **antimicrobial** (active against *Staphylococcus aureus*, *Enterococcus faecalis*, *Streptococcus pyogenes*), spasmolytic, analgesic, hepatoprotective, and wound-healing properties[1][3][5][6][8]. **Flavonoid and phenolic fractions** are believed responsible for much of the anti-inflammatory activity, acting partly as **COX-1 and COX-2 inhibitors**[1]. The extract is generally considered **non-toxic** (toxicity class V, LD₅₀ > 5000 mg/kg)[1]. **Route of administration** includes oral (tablets, capsules, teas, 3D-printed gels), topical (ointments for wound healing), and liquid oral/infusion forms[7][8]. **Standardization** (European Pharmacopoeia) typically requires a minimum flavonoid content of 0.5% (expressed as hyperoside)[1].

Brand names
solidaginis herba extract
Other names
goldenrod herb extractSolidago extractSolidago canadensis extractSolidago virgaurea extractgoldenrod extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on solidaginis herba extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on solidaginis herba extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call